Cloud9

Cloud Pharmaceuticals is a private biotechnology company focused on artificial intelligence-enabled drug discovery and development. The company applies generative AI, cloud computing, and molecular modeling to support target evaluation, molecule discovery, preclinical optimization, and clinical planning for novel therapeutics. Its historical core expertise appears to be small molecule discovery, and the company also highlights broader AI capabilities spanning drug repurposing, biomarker discovery, and clinical development workflows. Cloud describes itself as a multi-asset, multi-stage biotech with a partnered and diversified pipeline, but it does not publicly provide enough current program-level detail to verify named clinical assets. The business also has ties to spinout Polaris Quantum Biotech and to healthcare AI initiatives beyond therapeutics.